BioSpace News Archive

Drug Development

First Wave BioPharma Announces Restructuring of Merger Consideration Payment Terms With Former Shareholders of First Wave Bio

First Wave BioPharma, Inc. today announced that it has agreed with the former shareholders of First Wave Bio, Inc. (“FWB”) to amend the payment structure of the initial merger consideration and extend payments into 2023

November 16, 2021
·
4 min read
Business

Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection

Viatris Inc. (NASDAQ: VTRS) and Biocon Biologics Ltd. today announced the U.S. launch of interchangeable biosimilars SEMGLEE® (insulin glargine-yfgn) injection

November 16, 2021
·
11 min read
Deals

Resonetics Announces Acquisition of Hudson Medical Innovations

Resonetics announced today that it has acquired Hudson Medical Innovations ( Hudson ), a leading manufacturer of microfluidics, point-of-care diagnostics (including application of reagents), biosensors, and advanced wound care devices

November 16, 2021
·
2 min read
Business

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings

Ncardia forms strategic partnership with Kiniciti to build GMP capabilities to support iPSC cell therapy platforms and human cell-based in vitro discovery services

November 16, 2021
·
4 min read
Genetown

Bruker Announces Collaborative Advances in CCS-Enabled 4D Proteomics Workflows at HUPO

Bruker Corporation (Nasdaq: BRKR) announced major advances in collision cross section (CCS) enabled 4D proteomics workflows on the unique timsTOF multiomics platform.

November 16, 2021
·
6 min read
Pharm Country

Genenta To Present Updated Phase I/II Data At Upcoming Scientific Congresses SNO AND ASH

Genenta Science announced today that it will be presenting updated preliminary Phase I/II clinical data on Temferon at two upcoming scientific congresses.

November 16, 2021
·
1 min read
Business

Mydecine Reports Third Quarter 2021 Financial Results and Provides Business Update

Mydecine Innovations Group today reported its financial results for the third quarter ended September 30, 2021 and provided a business update.

November 16, 2021
·
10 min read
Pharm Country

Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021

Tilray, Inc. (“ Tilray ”) (Nasdaq: TLRY; TSX: TLRY), invites all stockholders of record to attend the Annual Meeting of Stockholders (“Annual Meeting”) which will be held on November 22, 2021 at 11:00 a.m. EST.

November 16, 2021
·
3 min read
Business

illumigyn™ Signs Distribution Agreement with Peramare Pharmaceuticals Nigeria Limited to bring its Innovative Gynecological Imaging Platform and Cloud System to Nigeria

illumigyn announced today its new distribution agreement with Peramare Pharmaceuticals Nigeria Limited to deploy 5,000 Gynescopes in Nigeria by 2026, making women’s health care accessible and affordable worldwide.

November 16, 2021
·
2 min read
Biotech Beach

CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology

CURE Pharmaceutical Holding Corp. announced today that it received an issue notification from the U.S. Patent Office (USPTO) stating that U.S. Patent No. 11,179,331 (the ’331 patent) is set to issue on November 23, 2021.

November 16, 2021
·
3 min read